The goal of this randomized, double-blind, crossover trial is to test the hypothesis that a longer-term indoor HEPA filtration intervention can improve cardiometabolic profiles by reducing indoor PM2.5 exposures in at-risk individuals.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in HOMA-IR
Timeframe: At the baseline and immediately after each of the 6-month interventions
Change in HbA1c
Timeframe: At the baseline and immediately after each of the 6-month interventions